| 1 |
Lee J, Roh JL. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience. Cancer Lett 2023;559:216119. [PMID: 36893895 DOI: 10.1016/j.canlet.2023.216119] [Reference Citation Analysis]
|
| 2 |
Wang H, Guan Y, Li C, Chen J, Yue S, Qian J, Dai B, Jiang C, Wen C, Wen L, Liang C, Zhang Y, Zhang L. PEGylated Manganese-Zinc Ferrite Nanocrystals Combined with Intratumoral Implantation of Micromagnets Enabled Synergetic Prostate Cancer Therapy via Ferroptotic and Immunogenic Cell Death. Small 2023;:e2207077. [PMID: 36861297 DOI: 10.1002/smll.202207077] [Reference Citation Analysis]
|
| 3 |
Yu H, Yan J, Li Z, Yang L, Ju F, Sun Y. Recent trends in emerging strategies for ferroptosis-based cancer therapy. Nanoscale Adv 2023;5:1271-90. [PMID: 36866253 DOI: 10.1039/d2na00719c] [Reference Citation Analysis]
|
| 4 |
Zhao D, Huang X, Tian Y, Zou J, Wang F, Chen X. Fluorescence Imaging-Incorporated Transcriptome Study of Glutathione Depletion-Enhanced Ferroptosis Therapy via Targeting Gold Nanoclusters. ACS Appl Mater Interfaces 2023;15:6385-96. [PMID: 36704920 DOI: 10.1021/acsami.2c18289] [Reference Citation Analysis]
|
| 5 |
Yin W, Chang J, Sun J, Zhang T, Zhao Y, Li Y, Dong H. Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy. J Mater Chem B 2023;11:1171-90. [PMID: 36650960 DOI: 10.1039/d2tb02161g] [Reference Citation Analysis]
|
| 6 |
Gu Y, Li Y, Wang J, Zhang L, Zhang J, Wang Y. Targeting ferroptosis: Paving new roads for drug design and discovery. Eur J Med Chem 2023;247:115015. [PMID: 36543035 DOI: 10.1016/j.ejmech.2022.115015] [Reference Citation Analysis]
|
| 7 |
Zhao X, Zhang J, Zhang W, Guo Z, Wei W, Wang X, Zhao J. A chiral fluorescent Ir(iii) complex that targets the GPX4 and ErbB pathways to induce cellular ferroptosis. Chem Sci 2023;14:1114-22. [PMID: 36756328 DOI: 10.1039/d2sc06171f] [Reference Citation Analysis]
|
| 8 |
Liu Y, Chen J, He Z, Luo H, Liu X, Sun Y, Ge D, Liu X, Shi W. Ferrocene-liposome-PEG: a robust ˙OH/lipid peroxide nano-converter for inducing tumor ferroptosis. Biomater Sci 2023;11:542-53. [PMID: 36472166 DOI: 10.1039/d2bm01172g] [Reference Citation Analysis]
|
| 9 |
Stepanić V, Kučerová-Chlupáčová M. Review and Chemoinformatic Analysis of Ferroptosis Modulators with a Focus on Natural Plant Products. Molecules 2023;28. [PMID: 36677534 DOI: 10.3390/molecules28020475] [Reference Citation Analysis]
|
| 10 |
Liang Y, Su Z, Mao X, Wan S, Luo L. Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases. Front Pharmacol 2023;14:1152326. [PMID: 36874022 DOI: 10.3389/fphar.2023.1152326] [Reference Citation Analysis]
|
| 11 |
谭 静. Research Progress of Serum Ferritin in the Treatment of Adult Acute Myeloid Leukemia. ACM 2023;13:3450-3456. [DOI: 10.12677/acm.2023.133492] [Reference Citation Analysis]
|
| 12 |
Wang J, Zhao Z, Liu Y, Cao X, Li F, Ran H, Cao Y, Wu C. 'Mito-Bomb': a novel mitochondria-targeting nanosystem for ferroptosis-boosted sonodynamic antitumor therapy. Drug Deliv 2022;29:3111-22. [PMID: 36131565 DOI: 10.1080/10717544.2022.2126027] [Reference Citation Analysis]
|
| 13 |
Kavvadas E. C3d(g), iron nanoparticles, hemin and cytochrome c may induce oxidative cytotoxicity in tumors and reduce tumor-associated myeloid cells-mediated immunosuppression. Medical Hypotheses 2022;167:110944. [DOI: 10.1016/j.mehy.2022.110944] [Reference Citation Analysis]
|
| 14 |
Ning X, Qi H, Yuan Y, Li R, Wang Y, Lin Z, Yin Y. Identification of a new small molecule that initiates ferroptosis in cancer cells by inhibiting the system Xc- to deplete GSH. Eur J Pharmacol 2022;:175304. [PMID: 36174666 DOI: 10.1016/j.ejphar.2022.175304] [Reference Citation Analysis]
|
| 15 |
Ma H, Dong Y, Chu Y, Guo Y, Li L. The mechanisms of ferroptosis and its role in alzheimer’s disease. Front Mol Biosci 2022;9:965064. [DOI: 10.3389/fmolb.2022.965064] [Reference Citation Analysis]
|
| 16 |
Sun Y, Xue Z, Huang T, Che X, Wu G. Lipid metabolism in ferroptosis and ferroptosis-based cancer therapy. Front Oncol 2022;12:941618. [DOI: 10.3389/fonc.2022.941618] [Reference Citation Analysis]
|
| 17 |
Wang J, Yang W, He X, Zhang Z, Zheng X. Assembling p53 Activating Peptide With CeO2 Nanoparticle to Construct a Metallo-Organic Supermolecule Toward the Synergistic Ferroptosis of Tumor. Front Bioeng Biotechnol 2022;10:929536. [DOI: 10.3389/fbioe.2022.929536] [Reference Citation Analysis]
|
| 18 |
Wang D, Tang L, Zhang Y, Ge G, Jiang X, Mo Y, Wu P, Deng X, Li L, Zuo S, Yan Q, Zhang S, Wang F, Shi L, Li X, Xiang B, Zhou M, Liao Q, Guo C, Zeng Z, Xiong W, Gong Z. Regulatory pathways and drugs associated with ferroptosis in tumors. Cell Death Dis 2022;13:544. [PMID: 35688814 DOI: 10.1038/s41419-022-04927-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 19 |
Bano I, Horky P, Abbas SQ, Majid M, Bilal AHM, Ali F, Behl T, Hassan SSU, Bungau S. Ferroptosis: A New Road towards Cancer Management. Molecules 2022;27:2129. [PMID: 35408533 DOI: 10.3390/molecules27072129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 20 |
Tang X, Jiang F, Wang X, Xia Y, Mao Y, Chen Y. Identification of the Ferroptosis-Related Long Non-Coding RNAs Signature to Improve the Prognosis Prediction in Papillary Renal Cell Carcinoma. Front Surg 2022;9:741726. [DOI: 10.3389/fsurg.2022.741726] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
|
